Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Endocrinology

• Publication date

  2005-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1677/JOE.1.05818PMID 15749809
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural requirements of the N-terminal region of GLP-1-[7-37]-NH2 for receptor interaction and cAMP production.

  2004cited by this paper
• The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose.

  2003cited by this paper
• Glucagon-Like Peptide 1 Receptor Agonist ZP10A Increases Insulin mRNA Expression and Prevents Diabetic Progression in db/db Mice

  2003cited by this paper
• Glucotoxicity and beta-cell failure in type 2 diabetes mellitus.

  2003cited by this paper
• Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells.

  2003cited by this paper
• Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes

  2003cited by this paper
• Specific and combined effects of insulin and glucose on functional pancreatic beta-cell mass in vivo in adult rats.

  2003cited by this paper
• The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

  2003cited by this paper
• Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes.

  2003cited by this paper
• Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

  2003cited by this paper
• Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis*

  2003cited by this paper
• Islet β-cell secretion determines glucagon release from neighbouring α-cells

  2003cited by this paper
• β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

  2003cited by this paper
• Glucagon-Like Peptide 1 Receptor Agonist ZP 10 A Increases Insulin mRNA Expression and Prevents Diabetic Progression in db / db Mice

  2003cited by this paper
• Glucotoxicity and β-Cell Failure in Type 2 Diabetes Mellitus

  2003cited by this paper
• Exendin 4 up-regulates expression of PDX 1 and hastens differentiation and maturation of human fetal pancreatic cells.

  2002cited by this paper
• Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans.

  2002cited by this paper
• Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

  2002cited by this paper
• Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.

  2002cited by this paper
• Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

  2002cited by this paper
• Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.

  2002cited by this paper
• Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice

  2002cited by this paper
• Minireview: the glucagon-like peptides.

  2001influential reference
• Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.

  2001cited by this paper
• Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation.

  2001cited by this paper
• beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes.

  2001cited by this paper
• Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets.

  2001cited by this paper
• IPF1/PDX1 deficiency and beta-cell dysfunction in Psammomys obesus, an animal With type 2 diabetes.

  2001influential reference
• Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.

  2001cited by this paper
• Protein Kinase Cζ Activation Mediates Glucagon-Like Peptide-1–Induced Pancreatic β-Cell Proliferation

  2001cited by this paper
• Glucagon-Like Peptide-1 Induces Cell Proliferation and Pancreatic-Duodenum Homeobox-1 Expression and Increases Endocrine Cell Mass in the Pancreas of Old, Glucose-Intolerant Rats.

  2000cited by this paper
• Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.

  2000cited by this paper
• Interaction between genetic and dietary factors determines beta-cell function in Psammomys obesus, an animal model of type 2 diabetes.

  1999cited by this paper
• Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells

  1999influential reference
• Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes.

  1999influential reference
• Glucagon-Like Peptide-1 Regulates the Beta Cell Transcription Factor, PDX-1, in Insulinoma Cells.

  1999influential reference
• Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells.

  1999cited by this paper
• Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.

  1999influential reference
• Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

  1998cited by this paper
• Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene

  1996cited by this paper
• Purification of the beta-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells.

  1996cited by this paper
• Increased susceptibility of islets from diabetes-prone Psammomys obesus to the deleterious effects of chronic glucose exposure.

  1996cited by this paper
• Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.

  1995cited by this paper
• Hyperproinsulinemia in the diabetic Psammomys obesus is a result of increased secretory demand on the beta-cell.

  1995cited by this paper
• Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible?

  1995cited by this paper
• Hyperproinsulinemia and insulin deficiency in the diabetic Psammomys obesus.

  1994influential reference
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

  1992cited by this paper
• Characterization of Stages in Development of Obesity-Diabetes Syndrome in Sand Rat (Psammomys obesus)

  1986cited by this paper

• Investigation of the Effect of Quercetin on Neurological Alterations During Type 2 Diabetes Mellitus in Swiss Albino Mice

  2019cites this paper
• Revisiting amino acids and peptides as anti-glycation agents.

  2018cites this paper
• Obesity, Insulin Resistance, and Metabolic Syndrome: A Study in WNIN/Ob Rats from a Pancreatic Perspective

  2013cites this paper
• Chapter 54 – Sand Rat

  2012cites this paper
• Diet-induced diabetes in the sand rat (Psammomys obesus).

  2012cites this paper
• Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus.

  2010cites this paper
• A Review of Islet of Langerhans Degeneration in Rodent Models of Type 2 Diabetes

  2008cites this paper
• Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness.

  2007cites this paper
• Animal models in type 2 diabetes research: an overview.

  2007cites this paper
• Péptidos anorexigénicos y su participación en la conducta alimentaria

  2005cites this paper
• Osteopenia in pediatric patients : when and and how to intervene ?

  2005cites this paper
• Annals of the New York Academy of Sciences Gastrointestinal Hormones and the Regulation of Β-cell Mass

  year unknowncites this paper